首頁 > 市場調查報告書 > 醫療設備

整形外科美容整形

市場調查報告書

商品編碼

1618256

乳房植入:市場洞察·競爭環境·市場預測 (～2030年)

Breast Implants - Market Insights, Competitive Landscape, and Market Forecast - 2030

出版日期: 2024年12月01日 | 出版商:

DelveInsight | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

簡介目錄圖表

乳房植入物市場規模預計將從 2023 年的 18 億美元增長到 2030 年的 27 億美元，預測期內複合年增長率為 7.00%。

由於乳癌患者數量的增加、產品開發活動的增加、乳房重建和整容手術的增加以及各種乳房植入物的可用性等因素，該市場正在經歷顯著增長。

乳房植入物：市場動態

根據 Globocan 2024 的數據，全球有 2,296,840 人被診斷出罹患乳癌。此外，同一來源報告稱，亞洲有 985,817 名乳癌患者，歐洲有 557,532 名乳癌患者，非洲有 198,553 名乳癌患者。全球乳癌的高發生率推動了對乳房重建方案（包括植入物）的需求，因為許多患者在乳房切除術後尋求重建手術。

主要參與者的各種產品開發活動預計也將進一步提振市場。

按產品類型劃分，鹽水乳房植入物預計將在 2023 年佔據重要的市場佔有率。這是由於與鹽水乳房植入物相關的各種特徵。

鹽水植入物通常被認為在破裂的情況下更安全，因為身體可以吸收鹽水而不會產生副作用。這種安全優勢在嚴格的監管標準優先考慮病人安全的市場中尤為重要，有助於提高採用率。

此外，由於鹽水植入物在插入後會被填充，因此插入時所需的切口較少，這對尋求疤痕較少的微創手術的患者很有吸引力。此外，鹽水植入物設計的進步，例如改進的外殼技術和可調節的體積選項，提高了耐用性、美觀效果和可自訂性，使其成為對患者和外科醫生都有吸引力的選擇。

本報告提供全球乳房植入的市場調查，彙整市場概要，市場影響因素及市場機會分析，法律制度，市場規模的轉變·預測，各種區分·地區/各主要國家的詳細分析，競爭情形，主要企業簡介等資訊。

推動市場要素
- 乳癌患者數量增加
- 增加產品開發活動
- 乳房重建手術及整形手術增加
- 有多種乳房植入物可供選擇
市場限制與課題
- 與乳房植入物相關的潛在風險
- 與隆乳手術相關的高額費用
市場機會
- 機器人輔助雷射手術的受歡迎程度
- 開發 3D 列印乳房植入物

第6章乳房植入市場:波特的五力分析

第7章乳房植入市場評估

各產品類型
- 矽乳房植入
- 生理食鹽水乳房植入
依形狀
- 圓形
- 解剖學
按紋理
- 平滑
- 紋理
各終端用戶
- 醫院
- 門診病人手術中心
- 其他
各地區
- 北美
- 歐洲
- 亞太地區
- 其他地區

第8章乳房植入市場:企業·產品簡介

Johnson & Johnson Services, Inc.
HansBioMed
AbbVie Inc.
IDEAL IMPLANT INCORPORATED
Sebbin
GC Aesthetics
POLYTECH Health & Aesthetics GmbH
SurgiSil
Silimed
CEREPLAS
Establishment Labs

第9章 KOL的見解

第10章計劃的方法

第11章關於DelveInsight

第12章免責聲明·聯絡方式

簡介目錄圖表

Product Code: DIMDCL0375

Breast Implants Market by Product Type (Silicone Breast Implants and Saline Breast Implants), Shape (Round and Anatomical), Texture (Smooth and Textured), End-User (Hospitals, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World) is expected to advance at a substantial CAGR forecast till 2030 owing to the increasing instances of breast cancer and rising product developmental activities across the globe

The breast implants market was valued at USD 1.80 billion in 2023, growing at a CAGR of 7.00% during the forecast period from 2024 to 2030 to reach USD 2.70 billion by 2030. The breast implants market is experiencing significant growth due to the increasing instances of breast cancer, rising product developmental activities, rise in breast reconstructive and cosmetic surgeries, and the availability of a wide variety of breast implants that are acting as major factors contributing to the overall growth of the breast implants market during the forecast period from 2024 to 2030.

Breast Implants Market Dynamics:

According to Globocan 2024, it stated that globally 2,296,840 were affected by breast cancer. Furthermore, the same source stated that Asia accounted for 985,817 breast cancer cases, Europe accounted for 557,532 breast cancer cases, and Africa accounted for 198,553 breast cancer cases. The high global incidence of breast cancer is driving demand for breast reconstruction options, including implants, as many patients seek reconstructive surgery post-mastectomy. This trend is expanding the market for breast implants, supporting physical and emotional recovery for survivors.

Various product developmental activities by the key market players will further boost the market for the same. For instance, in September 2024, GC Aesthetics(R) (GCA), a leading medical technology company committed to advancing women's health through innovative aesthetic and reconstructive breast solutions, announced the launch of the YOUTHLY(TM) brand in China, featuring its latest breast implant innovations; PERLE(TM), Luna XT(TM), and the latest version of The Round Collection(TM), 100% filled.

Additionally, in August 2024, CollPlant and Stratasys announced the pre-clinical study for regenerative breast implants with 200cc commercial-sized regenerative implants printed on a Stratasys Origin 3D printer.

Hence, the interplay of all the above-mentioned factors is expected to drive the breast implant market during the given forecast period from 2024 to 2030.

However, the potential risks associated with breast implants, the high cost associated with breast augmentation procedures, and others may restrict the market growth for the breast implants market.

Breast Implants Market Segment Analysis:

In the product type segment of the breast implants market, saline breast implants are anticipated to hold a significant market share in the year 2023. This is due to various features associated with saline breast implants.

Saline implants are generally considered safer in cases of rupture, as the body can absorb the saline solution without adverse effects. This safety advantage is particularly important in markets where stringent regulatory standards prioritize patient safety, contributing to higher adoption rates.

Additionally, saline implants require a smaller incision for insertion, as they are filled after placement, which appeals to patients seeking minimally invasive procedures with reduced scarring. Furthermore, advancements in saline implant design, such as improved shell technology and adjustable volume options, have enhanced their durability, aesthetic outcomes, and customization, making them an attractive option for both patients and surgeons.

Additionally, in May 2024, Bimini Health Tech assembled a comprehensive portfolio incorporating the Serene structured saline breast implant, an Acellular Dermal Matrix (ADM), and the Puregraft family of fat transfer products.

Therefore, the widespread uses and various advantages of saline breast implant that enhance performance and usability, solidifying a significant impact on the growth of the overall breast implants market during the forecast period from 2024 to 2030.

North America is expected to dominate the overall breast implant market:

Among all the regions, North America is estimated to hold a significant revenue share in the breast implant market. This can be attributed to several factors including the growing number of breast cosmetic surgeries and reconstruction procedures, increasing instances of breast cancer, and the continuous advancement of technology in this field, which offers improved treatment features and efficiency, acting as key factors that contribute to the growth of the breast implants market in the North America region during the forecast period from 2024 to 2030.

According to the American Society of Plastic Surgeons 2024, it stated that in 2022, there were about 304,181 breast augmentation procedures in the US. The same source further stated that about 157,740 breast reconstruction procedures happened in the year 2022. Thus, the growing number of breast cosmetic surgeries and reconstruction procedures is anticipated to surge the demand for breast implants in the region, thereby propelling the market for the same.

As per data from Globocan 2024, it stated that in the year 2022, 274,375 people in the US and 31,823 people in Canada were affected by breast cancer. The high incidence of breast cancer in the region is driving the demand for breast implants, as many patients seek reconstructive surgery post-treatment. This trend highlights a growing market for breast implants, with a focus on supporting patients' recovery and body confidence.

Various product developmental strategies by key players in the region play a major role in pushing forward the revenue shares of breast implants in the region. For example, in October 2021, AbbVie, a manufacturer of breast implants launched a breast cancer campaign to highlight reconstruction options among women. Moreover, product launches by key market players in the region is further expected to propel the growth of the North America breast implants market.

Therefore, the interplay of all the factors mentioned above would provide a conducive growth environment for the North America region in the breast implants market during the forecast period from 2024 to 2030.

Breast Implants Market key players:

Some of the key market players operating in the breast implants market include Johnson & Johnson Services, Inc., Hans BioMed., AbbVie Inc., IDEAL IMPLANT INCORPORATED, Sebbin, GC Aesthetics, POLYTECH Health & Aesthetics GmbH, SurgiSil, Silimed, CEREPLAS, Establishment Labs, and others.

Recent Developmental Activities in the Breast Implants Market:

In September 2024, Establishment Labs announced the US Food and Drug Administration (FDA) approval for its Motiva SmoothSilk Ergonomix and Motiva SmoothSilk Round breast implants.
In April 2024, GC Aesthetics, a leading designer, manufacturer, and distributor of breast implants and medical devices for the global aesthetics industry, announced the micro-textured anatomical breast implant LUNA XT. It is the first breast implant in the world approved under the new European Medical Device Regulation (MDR).
In May 2021, GC Aesthetics, Inc., a privately-held medical technology company providing aesthetic solutions launched its next generation of breast implants, PERLE(TM).
In January 2021, Mentor Worldwide LLC, a part of the Johnson & Johnson Medical Devices Companies received the US Food and Drug Administration (FDA) approval for the MENTOR(R) MemoryGel BOOST(TM) Breast Implant for breast augmentation in women at least 22 years old, and for women of all ages undergoing breast reconstruction.

Key takeaways from the Breast Implants market report study

Market size analysis for current breast implants market size (2023), and market forecast for 6 years (2024 to 2030)
Top key product/services developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years
Key companies dominating the breast implants market
Various opportunities available for the other competitors in the breast implants market space
What are the top-performing segments in 2023? How these segments will perform in 2030?
Which are the top-performing regions and countries in the current breast implant market scenario?
Which are the regions and countries where companies should have concentrated on opportunities for breast implant market growth in the coming future?

Target audience who can be benefited from this Breast Implants market report study

Breast implant providers
Research organizations and consulting companies
Breast Implant related organizations, associations, forums, and other alliances
Government and corporate offices
Start-up companies, venture capitalists, and private equity firms
Distributors and traders dealing in breast implants
Various end-users who want to know more about the breast implant market and the latest developments in the breast implant market

Frequently Asked Questions for the Breast Implants Market:

1. What are breast implants?

The breast implants are prostheses (artificial devices) that are surgically inserted in the breast to change the shape, size, and contour of a person's breast. These implants are generally used for restoring a natural breast appearance following a mastectomy, to correct congenital defects and deformities of the chest wall, or, cosmetically, to enhance the look of the breast through breast augmentation surgery.

2. What is the market for breast implants?

The breast implants market was valued at USD 1.80 billion in 2023, growing at a CAGR of 7.00% during the forecast period from 2024 to 2030 to reach USD 2.70 billion by 2030.

3. What are the drivers for the breast implants market?

The breast implants market is experiencing significant growth due to the increasing instances of breast cancer, rising product developmental activities, rise in breast reconstructive and cosmetic surgeries, and availability of a wide variety of breast implants that are acting as major factors contributing to the overall growth of the breast implants market during the forecast period from 2024 to 2030.

4. Who are the key players operating in the breast implants market?

Some of the major market players operating in the breast implants market include Johnson & Johnson Services, Inc., HansBioMed, AbbVie Inc., IDEAL IMPLANT INCORPORATED, Sebbin, GC Aesthetics, POLYTECH Health & Aesthetics GmbH, SurgiSil, Silimed, CEREPLAS, Establishment Labs, and others.

5. Which region has the highest share in the breast implant market?

Among all the regions, North America is estimated to hold a significant revenue share in the breast implant market. This can be attributed to several factors including the growing number of breast cosmetic surgeries and reconstruction procedures, increasing instances of breast cancer, and the continuous advancement of technology in this field, which offers improved treatment features and efficiency, which are the major key factors that contribute to the growth of the breast implants market in the North America region during the forecast period from 2024 to 2030.

1. Breast Implants Market Report Introduction

1.1. Scope of the Study
1.2. Market Segmentation
1.3. Market Assumption

2. Breast Implants Market Executive Summary

2.1. Market at Glance

3. Competitive Landscape

4. Regulatory Analysis

4.1. The United States
4.2. Europe
4.3. Japan
4.4. China

5. Breast Implants Market Key Factors Analysis

5.1. Breast Implants Market Drivers
- 5.1.1. Increasing cases of breast cancer
- 5.1.2. Rising product developmental activities
- 5.1.3. Rise in breast reconstructive and cosmetic surgeries
- 5.1.4. Availability of a wide variety of breast implants
5.2. Breast Implants Market Restraints and Challenges
- 5.2.1. Potential risk associated with breast implants
- 5.2.2. High cost associated with breast augmentation procedures
5.3. Breast Implants Market Opportunities
- 5.3.1. Growing popularity of robot-assisted laser surgeries
- 5.3.2. Development of 3D printed breast implants

6. Breast Implants Market Porter's Five Forces Analysis

6.1. Bargaining Power of Suppliers
6.2. Bargaining Power of Consumers
6.3. Threat of New Entrants
6.4. Threat of Substitutes
6.5. Competitive Rivalry

7. Breast Implants Market Assessment

7.1. By Product Type
- 7.1.1. Silicone Breast Implants
- 7.1.2. Saline Breast Implants
7.2. By Shape
- 7.2.1. Round
- 7.2.2. Anatomical
7.3. By Texture
- 7.3.1. Smooth
- 7.3.2. Textured
7.4. By End-User
- 7.4.1. Hospitals
- 7.4.2. Ambulatory Surgical Centers
- 7.4.3. Others
7.5. By Geography
- 7.5.1. North America
  - 7.5.1.1. United States Breast Implants Market Size in USD million (2021-2030)
  - 7.5.1.2. Canada Breast Implants Market Size in USD million (2021-2030)
  - 7.5.1.3. Mexico Breast Implants Market Size in USD million (2021-2030)
- 7.5.2. Europe
  - 7.5.2.1. France Breast Implants Market Size in USD million (2021-2030)
  - 7.5.2.2. Germany Breast Implants Market Size in USD million (2021-2030)
  - 7.5.2.3. United Kingdom Breast Implants Market Size in USD million (2021-2030)
  - 7.5.2.4. Italy Breast Implants market size in USD million (2021-2030)
  - 7.5.2.5. Spain Breast Implants Market Size in USD million (2021-2030)
  - 7.5.2.6. Rest of Europe Breast Implants Market Size in USD million (2021-2030)
- 7.5.3. Asia-Pacific
  - 7.5.3.1. China Breast Implants Market Size in USD million (2021-2030)
  - 7.5.3.2. Japan Breast Implants Market Size in USD million (2021-2030)
  - 7.5.3.3. India Breast Implants Market Size in USD million (2021-2030)
  - 7.5.3.4. Australia Breast Implants Market Size in USD million (2021-2030)
  - 7.5.3.5. South Korea Breast Implants Market Size in USD million (2021-2030)
  - 7.5.3.6. Rest of Asia-Pacific Breast Implants Market Size in USD million (2021-2030)
- 7.5.4. Rest of the World (RoW)
  - 7.5.4.1. Middle East Breast Implants Market Size in USD million (2021-2030)
  - 7.5.4.2. Africa Breast Implants Market Size in USD million (2021-2030)
  - 7.5.4.3. South America Breast Implants Market Size in USD million (2021-2030)

8. Breast Implants Market Company and Product Profiles

8.1. Johnson & Johnson Services, Inc.
- 8.1.1. Company Overview
- 8.1.2. Company Snapshot
- 8.1.3. Financial Overview
- 8.1.4. Product Listing
- 8.1.5. Entropy
8.2. HansBioMed
- 8.2.1. Company Overview
- 8.2.2. Company Snapshot
- 8.2.3. Financial Overview
- 8.2.4. Product Listing
- 8.2.5. Entropy
8.3. AbbVie Inc.
- 8.3.1. Company Overview
- 8.3.2. Company Snapshot
- 8.3.3. Financial Overview
- 8.3.4. Product Listing
- 8.3.5. Entropy
8.4. IDEAL IMPLANT INCORPORATED
- 8.4.1. Company Overview
- 8.4.2. Company Snapshot
- 8.4.3. Financial Overview
- 8.4.4. Product Listing
- 8.4.5. Entropy
8.5. Sebbin
- 8.5.1. Company Overview
- 8.5.2. Company Snapshot
- 8.5.3. Financial Overview
- 8.5.4. Product Listing
- 8.5.5. Entropy
8.6. GC Aesthetics
- 8.6.1. Company Overview
- 8.6.2. Company Snapshot
- 8.6.3. Financial Overview
- 8.6.4. Product Listing
- 8.6.5. Entropy
8.7. POLYTECH Health & Aesthetics GmbH
- 8.7.1. Company Overview
- 8.7.2. Company Snapshot
- 8.7.3. Financial Overview
- 8.7.4. Product Listing
- 8.7.5. Entropy
8.8. SurgiSil
- 8.8.1. Company Overview
- 8.8.2. Company Snapshot
- 8.8.3. Financial Overview
- 8.8.4. Product Listing
- 8.8.5. Entropy
8.9. Silimed
- 8.9.1. Company Overview
- 8.9.2. Company Snapshot
- 8.9.3. Financial Overview
- 8.9.4. Product Listing
- 8.9.5. Entropy
8.10. CEREPLAS
- 8.10.1. Company Overview
- 8.10.2. Company Snapshot
- 8.10.3. Financial Overview
- 8.10.4. Product Listing
- 8.10.5. Entropy
8.11. Establishment Labs
- 8.11.1. Company Overview
- 8.11.2. Company Snapshot
- 8.11.3. Financial Overview
- 8.11.4. Product Listing
- 8.11.5. Entropy